Albertsons Companies, Inc. Announces Proposed Senior Notes Offering — Neutral

ACI   Business Wire — October 21, 2025

BOISE, Idaho--(BUSINESS WIRE)--Albertsons Companies, Inc. (NYSE: ACI) (the “Company”) today announced its intention to offer $1,250 million aggregate principal amount of new senior notes due 2031 (the “2031 Notes”) and new senior notes due 2034 (the “2034 Notes” and together with the 2031 Notes, the “Notes”). The Company and its subsidiaries, Safeway Inc., New Albertsons L.P., Albertson's LLC and Albertsons Safeway LLC, will be co-issuers of the Notes. The Company intends to use the net proceed.

image for news Albertsons Companies, Inc. Announces Proposed Senior Notes Offering

PITTSBURGH, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) ("Eos" or the “Company”), an American energy company and the leading innovator in designing, sourcing, manufacturing, and providing zinc-based battery energy storage systems (BESS), and Talen Energy Corporation (NASDAQ: TLN), one of the nation's largest independent power producers and energy infrastructure companies, today announced a strategic collaboration to develop energy storage capacity across Pennsylvania to help meet the state's growing demand and support artificial intelligence (AI) infrastructure.

image for news Eos Energy and Talen Energy Announce Strategic Collaboration to Advance Power Capacity for AI Infrastructure in Pennsylvania

KBR Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO , Oct. 21, 2025 /PRNewswire/ -- A new class-action lawsuit is targeting KBR, Inc. (NYSE: KBR), alleging the company made misleading statements to investors in the weeks leading up to the abrupt cancellation of a major military contract. The suit, Norrman v.

image for news KBR, Inc. (KBR) Faces Securities Class Action Amid TRANSCOM Contract Termination-Hagens Berman

SAN FRANCISCO , Oct. 21, 2025 /PRNewswire/ -- A federal class-action lawsuit has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) following a devastating 83% drop in the biotech company's stock price after its lead drug candidate failed to meet its primary endpoint in a critical Phase 3 trial. Prominent shareholders rights firm Hagens Berman has been investigating the alleged claims.

image for news aTyr Pharma, Inc.'s (ATYR) Failed Drug Trial Spurs Securities Lawsuit -- Hagens Berman

Agreement underscores growing demand for U.S.-made energy storage that strengthens reliability and delivers long-duration flexibility to meet the needs of high-demand sectors Agreement underscores growing demand for U.S.-made energy storage that strengthens reliability and delivers long-duration flexibility to meet the needs of high-demand sectors

image for news MN8 Energy Signs Supply Agreement with Eos Energy to Deploy Up to 750 MWh of American-Made Long Duration Energy Storage Across Renewable Projects

MLTX Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO , Oct. 21, 2025 /PRNewswire/ -- A securities class action, styled Bridgewood v. MoonLake Immunotherapeutics, et al.

image for news MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman

Danaher (DHR) Q3 Earnings and Revenues Beat Estimates — Positive

DHR   Zacks Investment Research — October 21, 2025

Danaher (DHR) came out with quarterly earnings of $1.89 per share, beating the Zacks Consensus Estimate of $1.71 per share. This compares to earnings of $1.71 per share a year ago.

image for news Danaher (DHR) Q3 Earnings and Revenues Beat Estimates

Peoples Bancorp (PEBO) Q3 Earnings Top Estimates — Positive

PEBO   Zacks Investment Research — October 21, 2025

Peoples Bancorp (PEBO) came out with quarterly earnings of $0.9 per share, beating the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $0.89 per share a year ago.

image for news Peoples Bancorp (PEBO) Q3 Earnings Top Estimates

Dow Jones and S&P 500 futures turn green as GM and 3M outlooks impress — Positive

GM  IVV  MMM  SPLG  SPXL  SPY  SSO  UPRO  VOO   Proactive Investors — October 21, 2025

US stock futures pared their earlier losses as sentiment became more positive on Tuesday morning following some upbeat earnings releases. S&P 500 and Dow Jones futures flipped from red to green, though gains were less than 0.1%, while Nasdaq futures remained very slightly negative.

image for news Dow Jones and S&P 500 futures turn green as GM and 3M outlooks impress

Company completes first tranche of a $7 million financing to increase cash runway and maintain Nasdaq compliance SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo” or the “Company”), an innovative cellular immunotherapy company developing novel T cell therapeutics that incorporate phagocytic mechanisms, today announced that investigators have been authorized under the study protocol to administer a third infusion of CER-1236 to a patient enrolled in the first cohort of its ongoing Phase 1 clinical trial.

image for news CERo Therapeutics Announces Third Dose for Patient in Phase 1 Clinical Trial of CER-1236 in AML

HII Increases Quarterly Dividend to $1.38 per Share — Neutral

HII   GlobeNewsWire — October 21, 2025

NEWPORT NEWS, Va., Oct. 21, 2025 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced today that its Board of Directors has declared a quarterly cash dividend of $1.38 per share, a $0.03 increase over the $1.35 per share dividend paid in each of the prior four quarters. The $1.38 per share dividend will be payable on Dec. 12, 2025, to shareholders of record as of the close of business on Nov. 28, 2025.

image for news HII Increases Quarterly Dividend to $1.38 per Share

Defiance Launches IRE: The First 2X Long ETF for IREN Limited — Neutral

IREN   GlobeNewsWire — October 21, 2025

MIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Defiance ETFs is proud to announce the launch of the Defiance Daily Target 2X Long IREN ETF (Ticker: IRE) , expanding its suite of single-stock leveraged ETFs designed for active traders seeking amplified exposure to innovative, high-growth companies. The newest addition, IRE, is designed for traders who seek magnified, short-term bullish exposure to IREN Limited (NASDAQ: IREN), a global data center operator and Bitcoin mining company.

image for news Defiance Launches IRE: The First 2X Long ETF for IREN Limited

2 REITs That Missed Out On The Rally — Negative

CNNRF  CZR  GLPI  ILPT  MCD  VICI  VNQ   Seeking Alpha — October 21, 2025

Most REITs have risen a lot already. But some REITs have missed this recovery and remain discounted. I highlight two such companies that remain opportunistic.

image for news 2 REITs That Missed Out On The Rally

$24 million state-led economic development package underscores the shared commitment between Eos and Pennsylvania to advance U.S. manufacturing and job creation

image for news Eos Energy Executes Next Phase of Growth Strategy with U.S. Manufacturing Expansion and New Software Hub Under Project AMAZE

LFMD Investors with Losses Encouraged to Contact Hagens Berman Before Oct. 27th Deadline SAN FRANCISCO , Oct. 21, 2025 /PRNewswire/ -- A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its executives provided investors with a misleading picture of its financial health and growth prospects. The suit, filed in in the Eastern District of New York, comes after a dramatic stock price decline in August following the company's earnings report.

image for news LFMD 6-DAY DEADLINE ALERT: Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman

Media Release COPENHAGEN, Denmark; October 21, 2025 Genmab A/S (Nasdaq: G MAB ) (“Genmab”) announced today that it is commencing, through a wholly owned subsidiary, Genmab Holding II B.V. (“ Purchaser ”), a cash tender offer (the “Offer”) to purchase all of the issued and outstanding common shares (“Common Shares”) of Merus N.V.

image for news Genmab Commences Tender Offer for All Issued and Outstanding Common Shares of Merus N.V.

Elevance Health (ELV) Tops Q3 Earnings and Revenue Estimates — Positive

ELV   Zacks Investment Research — October 21, 2025

Elevance Health (ELV) came out with quarterly earnings of $6.03 per share, beating the Zacks Consensus Estimate of $4.98 per share. This compares to earnings of $8.37 per share a year ago.

image for news Elevance Health (ELV) Tops Q3 Earnings and Revenue Estimates

Betting Big on Intel: Is INTC Stock a Buy Before Oct. 23 Earnings? — Positive

INTC   24/7 Wall Street — October 21, 2025

image for news Betting Big on Intel: Is INTC Stock a Buy Before Oct. 23 Earnings?

The defense contractor says it expects lower sales in its aeronautics-systems business for the full year.

image for news Northrop Grumman Stock Tumbles on Guidance Cut and Third-Quarter Sales Miss

VSee multi-year teleradiology contract with a major level 1 hospital is set to double annual recurring revenue and pave the path for expanding services across the U.S. SAN JOSE, CALIFORNIA / ACCESS Newswire / October 21, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a trailblazing leader in telehealth innovation, is thrilled to announce a monumental multi-year teleradiology contract that catapults the Company into a new era of unprecedented growth and shareholder value creation. Executed on May 7, 2025, with service delivery underway since June 15, 2025, this landmark deal with a premier Level 1 hospital system is set to double VSee's …

image for news VSee Health (Nasdaq:VSEE) Secures Game-Changing 10M+ Teleradiology Contract, Igniting Explosive Growth in Booming Telehealth Sector